Silexion Therapeutics Ltd. (SLXNW) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q1'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 2K | 0 | 4K | 0 | 0 | 0 | 22K | 7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -2K | 0 | -4K | 0 | 0 | 0 | -22K | -7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | 81.82% | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 2.75M | -18.86M | 3.29M | 2.28M | 1.65M | 23.24K | 8.04M | 1.39M | 1.25M | 1.73M | 731K | 155.47K | 808 | 488.11K | 237K | 156.99K | 350.24K | 433.4K | 92.65K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.38M | 1.03M | 1.13M | 1.26M | 1.06M | 12.48K | 4.8M | 612K | 281K | 465K | 186K | 155.47K | 127 | 488.11K | 237K | 156.99K | 350.24K | 433.4K | 92.65K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.37M | 3.38M | 2.16M | 1.02M | 590K | 871 | 3.22M | 766K | 961K | 1.26M | 535K | 0 | 681 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -1000K | 0 | 3K | 4K | 9.89K | 22K | 7K | 8K | 6K | 10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.75M | 18.86M | -3.29M | -2.28M | -1.65M | -23.24K | -8.04M | -1.39M | -1.25M | -1.73M | -731K | -155.47K | -808 | -488.11K | -237K | -156.99K | -350.24K | -433.4K | -92.65K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -66.61% | 81237.6% | 59.03% | -64.91% | -32% | 98.66% | -999.32% | -790.84% | -154602.97% | -254.02% | -208.44% | 0.97% | 99.77% | -12.62% | - | - | -278% | - | - |
| EBITDA | -2.75M | 18.86M | -3.29M | -2.28M | -1.65M | -23.24K | -8.01M | -1.38M | -1.24M | -1.72M | -721K | 162.95K | -793 | 494.41K | 292.58K | 42.69K | -246K | -242K | -97.75K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -66.89% | 81272.33% | 58.97% | -65.53% | -32.53% | 98.65% | -1011.51% | -945.67% | -156520.43% | -448.29% | -346.43% | 281.67% | 99.68% | 304.3% | - | - | -151.65% | - | - |
| D&A (Non-Cash Add-back) | 2K | 3K | 4K | 3K | 4K | 6 | 22K | 7K | 8K | 6K | 10K | 0 | 15 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -2.75M | -4.41M | -3.26M | -2.5M | -1.73M | -23.24K | -8.04M | -1.49M | -1.25M | -1.73M | -731K | 162.95K | -808 | 494.41K | 292.58K | 42.69K | -246K | -242K | -97.75K |
| Net Interest Income | 32K | 63K | 39K | 43K | -9K | 0 | -52K | 4K | 19K | 33K | 227.05K | 318K | 745.04K | 992.92K | 520.02K | 163.34K | 9.39K | 2.18K | 676 |
| Interest Income | 32K | 69K | 39K | 43K | 0 | 0 | 0 | 6K | 19K | 33K | 227.05K | 318K | 745.04K | 992.92K | 520.02K | 163.34K | 9.39K | 2.18K | 676 |
| Interest Expense | 0 | 6K | 0 | 0 | 9K | 0 | 52K | 2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 16K | -23.27M | 30K | -216K | -85K | 154K | -3.82M | -102K | -168K | 54K | -72K | 318.42K | 75 | 982.52K | 529.58K | 199.69K | 104.58K | 191.63K | -5.1K |
| Pretax Income | -2.73M | -4.41M | -3.26M | -2.5M | -1.74M | -31.27K | -11.86M | -1.49M | -1.42M | -1.67M | -803K | 162.95K | -733 | 494.41K | 292.58K | 42.69K | -245.66K | -241.77K | -97.75K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 3K | 0 | 19 | 2K | 2K | 5K | 6K | 6K | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | -0.12% | 0% | -0.06% | -0.02% | -0.13% | -0.35% | -0.36% | -0.75% | 0% | -1.36% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.73M | -4.41M | -3.26M | -2.5M | -1.74M | -31.14K | -11.85M | -1.47M | -1.37M | -1.73M | -787K | 162.95K | -774 | 494.41K | 292.58K | 42.69K | -246K | -242K | -97.75K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -57.52% | -14068.73% | 72.47% | -70.04% | -26.37% | 98.2% | -1405.85% | -1003.36% | -177290.18% | -449.51% | -368.99% | 281.67% | 99.69% | 304.3% | - | - | -151.65% | - | - |
| Net Income (Continuing) | -2.73M | -4.41M | -3.26M | -2.5M | -1.74M | -31.29K | -11.86M | -1.49M | -1.42M | -1.68M | -809K | 162.95K | -743 | 494.41K | 292.58K | 42.69K | -245.66K | -241.77K | -97.75K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.35M | 3.37M | 3.42M | 0 | 0 | 0 | 3.59M | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -8.50 | -14.10 | 28.80 | 43.20 | -2.60 | -1.90 | -11.50 | -0.30 | -12.70 | -17.80 | 0.13 | 0.27 | 0.26 | 0.33 | 0.20 | 0.03 | -0.15 | -0.15 | -0.06 |
| EPS Growth % | -226.92% | -642.11% | 350.43% | 14500% | 79.53% | 89.33% | -8682.09% | -209.49% | -4984.62% | -5445.35% | -31.98% | 953.85% | 274.5% | 326.53% | - | - | -152.54% | - | - |
| EPS (Basic) | -8.50 | -14.10 | 28.80 | 43.20 | -2.60 | -1.90 | -11.50 | -0.30 | -12.70 | -17.80 | 0.13 | 0.25 | 0.26 | 0.30 | 0.18 | 0.03 | -0.15 | -0.15 | -0.06 |
| Diluted Shares Outstanding | 323.04K | 312.67K | 113.27K | 57.95K | 677.92K | 924.36K | 647.57K | 430K | 111.73K | 97.12K | 552.77K | 660.51K | 1.21M | 1.65M | 1.65M | 1.65M | 1.65M | 1.65M | 1.65M |
| Basic Shares Outstanding | 323.04K | 312.67K | 113.27K | 57.95K | 677.92K | 924.36K | 647.57K | 430K | 111.73K | 97.12K | 552.77K | 660.51K | 1.21M | 1.65M | 1.65M | 1.65M | 1.65M | 1.65M | 1.65M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |